NFKB1 and lung carcinoma: Detailed mechanisms have been identified in prostate, breast, and lung cancer, such as AR dimerization (Maeda et al, 2022), ERα stabilization (Habara et al, 2022), and NF-κB activation (Erlejman et al, 2014; Zong et al, 2021), respectively.